These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 21568876

  • 21. 4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity.
    Liu F, Tang B, Liu H, Li L, Liu G, Cheng Y, Xu Y, Chen W, Huang Y.
    Anticancer Agents Med Chem; 2016; 16(12):1652-1664. PubMed ID: 27039919
    [Abstract] [Full Text] [Related]

  • 22. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.
    OuYang Y, Zou W, Peng L, Yang Z, Tang Q, Chen M, Jia S, Zhang H, Lan Z, Zheng P, Zhu W.
    Eur J Med Chem; 2018 Jun 25; 154():29-43. PubMed ID: 29775935
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM, Georgey HH, Youssef RM, El-Sayed NA.
    Eur J Med Chem; 2010 Dec 25; 45(12):6058-67. PubMed ID: 21051122
    [Abstract] [Full Text] [Related]

  • 24. Design, synthesis and biological evaluation of pyrazolylaminoquinazoline derivatives as highly potent pan-fibroblast growth factor receptor inhibitors.
    Fan J, Dai Y, Shao J, Peng X, Wang C, Cao S, Zhao B, Ai J, Geng M, Duan W.
    Bioorg Med Chem Lett; 2016 Jun 01; 26(11):2594-9. PubMed ID: 27117427
    [Abstract] [Full Text] [Related]

  • 25. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
    Ikeda T, Yaegashi T, Matsuzaki T, Yamazaki R, Hashimoto S, Sawada S.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5978-81. PubMed ID: 21865039
    [Abstract] [Full Text] [Related]

  • 26. Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
    Hu X, Wang Y, Xue J, Han T, Jiao R, Li Z, Liu W, Xu F, Hua H, Li D.
    Bioorg Med Chem Lett; 2017 Nov 15; 27(22):4989-4993. PubMed ID: 29037951
    [Abstract] [Full Text] [Related]

  • 27. Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents.
    Yassen AS, Elshihawy HE, Said MM, Abouzid KA.
    Chem Pharm Bull (Tokyo); 2014 Nov 15; 62(5):454-66. PubMed ID: 24789927
    [Abstract] [Full Text] [Related]

  • 28. Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors.
    Wang Z, Wu X, Wang L, Zhang J, Liu J, Song Z, Tang Z.
    Bioorg Med Chem Lett; 2016 Jun 01; 26(11):2589-93. PubMed ID: 27118497
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM, Abdel-Aziz AA, Al-Suwaidan IA, Abdel-Hamide SG, Shawer TZ, El-Azab AS.
    Eur J Med Chem; 2014 May 22; 79():446-54. PubMed ID: 24763265
    [Abstract] [Full Text] [Related]

  • 30. Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies.
    Jyothi Buggana S, Paturi MC, Perka H, Gade DR, Vvs RP.
    Comput Biol Chem; 2019 Apr 22; 79():110-118. PubMed ID: 30785020
    [Abstract] [Full Text] [Related]

  • 31. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM, Ashour AE.
    J Enzyme Inhib Med Chem; 2012 Aug 22; 27(4):541-5. PubMed ID: 21851213
    [Abstract] [Full Text] [Related]

  • 32. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.
    Qin X, Lv Y, Liu P, Li Z, Hu L, Zeng C, Yang L.
    Bioorg Med Chem Lett; 2016 Mar 15; 26(6):1571-1575. PubMed ID: 26879314
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
    Ding PP, Gao M, Mao BB, Cao SL, Liu CH, Yang CR, Li ZF, Liao J, Zhao H, Li Z, Li J, Wang H, Xu X.
    Eur J Med Chem; 2016 Jan 27; 108():364-373. PubMed ID: 26703795
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
    Rane RA, Naphade SS, Bangalore PK, Palkar MB, Patel HM, Shaikh MS, Alwan WS, Karpoormath R.
    Chem Biol Drug Des; 2015 Aug 27; 86(2):210-22. PubMed ID: 25418204
    [Abstract] [Full Text] [Related]

  • 37. Synthesis of New Proteomimetic Quinazolinone Alkaloids and Evaluation of Their Neuroprotective and Antitumor Effects.
    Long S, Resende DISP, Kijjoa A, Silva AMS, Fernandes R, Xavier CPR, Vasconcelos MH, Sousa E, Pinto MMM.
    Molecules; 2019 Feb 01; 24(3):. PubMed ID: 30717179
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and antitumor activity of novel 6,7,8-trimethoxy N-aryl-substituted-4-aminoquinazoline derivatives.
    Liu F, Huai Z, Xia G, Song L, Li S, Xu Y, Hong K, Yao M, Liu G, Huang Y.
    Bioorg Med Chem Lett; 2018 Aug 01; 28(14):2561-2565. PubMed ID: 29903662
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    Kamal A, Bharathi EV, Reddy JS, Ramaiah MJ, Dastagiri D, Reddy MK, Viswanath A, Reddy TL, Shaik TB, Pushpavalli SN, Bhadra MP.
    Eur J Med Chem; 2011 Feb 01; 46(2):691-703. PubMed ID: 21194809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.